flowbone raises CHF 2.1 million to bring nanomedicine-based bone repair to the market
Summary
flowbone raises CHF 2.1 million to bring nanomedicine-based bone repair to the marketflowbone, an EPFL spin-off active in the field of bone regeneration, has closed a seed round for CHF 2.1 million, mostly with experienced business angels. The funds enable the company to prepare its US market entry, including FDA clearance for a first bone repair product, and to continue its pre-clinical developments for the strengthening of osteoporotic bone. flowbone won a Venture Kick award in 2020 and was a Venture Leader Medtech in 2021. The startup was featured at the TOP 100 Swiss Startup Award in 2021.Co-founders of flowbone signing the official documents for the capital increase. From left to right: Prof. Dominique Pioletti, Dr. Ulrike Kettenberger, and Dr. R\xe9gis Gauderon.